Trial Profile
A Prospective, Observational, Open-Label Study Investigating the Effectiveness and Safety of Ledipasvir/Sofosbuvir in Adolescents with Hepatitis C Virus Genotype 4 Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Oct 2018
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 01 Oct 2018 New trial record
- 18 Sep 2018 Results published in the Pediatric Infectious Disease Journal